Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Capital Farma is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Spain
Founded:1999
Employees:605
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval O8NPPW
EMA · #APR-SONXIN8R · 2018-03-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-CL1QE9ER
Issued: 2020-03-27
Expires: 2025-07-26
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-30M4SKP4
Issued: 2020-02-09
Expires: 2025-05-13
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-HA9V3ZHD
Issued: 2020-04-28
Expires: 2025-07-22
WHO GMP
World Health Organization
Cert #: CERT-A1P00N4I
Issued: 2020-11-08
Expires: 2025-07-02
Loading CDMO intelligence...
Key facts about Capital Farma
- Capital Farma is headquartered in Spain.
- Capital Farma was founded in 1999.
- Capital Farma has 605 employees.
- Capital Farma's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Capital Farma
Directory pages this company appears in, each with the full list of matching manufacturers.